Heart
LIFE+TIMES
criteria.
Barostim, created by Minneapolis-based medtech company CVRx, received FDA PMA approval in 2019 and is now commercially available to reduce the symptoms of heart failure for patients who are not indicated for cardiac resynchronization therapy...
Read latest The Saratogian (Saratoga, NY) online.
Online newspapers
at PressDisplay.
Newspapers from United States
Newspapers in English